IULIUCCI JOHN D 4
4 · ARIAD PHARMACEUTICALS INC · Filed Oct 5, 2009
Insider Transaction Report
Form 4
IULIUCCI JOHN D
Senior VP, Development
Transactions
- Exercise/Conversion
Common Stock
2009-10-01$0.75/sh+70,000$52,500→ 202,742 total - Sale
Common Stock
2009-10-01$2.16/sh−70,000$151,543→ 132,742 total - Exercise/Conversion
Employee Stock Option (right to buy)
2009-10-01+70,000→ 0 totalExercise: $0.75Exp: 2009-10-04→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]Shares were sold pursuant to a previously filed 10b5-1 plan.
- [F2]Exercisable 25% on date of grant and 25% per quarter for the subsequent three quarters, subject to acceleration upon curtain events.